COMPUESTOS DERIVADOS DE IMIDAZOL CONDENSADOS, INHIBIDORES DEL FACTOR XA Y/O DEL FACTOR VLLA; COMPOSICION FARMACEUTICA; PROCESO DE PREPARACION; Y SU USO PARA TRATAR FIBRINOLISIS, LA FORMACION ANORMAL DE TROMBOS, INFARTO DE MIOCARDIO AGUDO, TRASTORNOS

Benzimidazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I, wherein R ; R ; R ; R ; R ; Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NAZARE MARC, WAGNER MICHAEL, WEHNER VOLKMAR, MATTER HANS, URMANN MATTHIAS, RITTER KURT
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NAZARE MARC
WAGNER MICHAEL
WEHNER VOLKMAR
MATTER HANS
URMANN MATTHIAS
RITTER KURT
description Benzimidazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I, wherein R ; R ; R ; R ; R ; Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2004001078A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2004001078A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2004001078A13</originalsourceid><addsrcrecordid>eNqNjzFPAzEMhW9hQIX_YIm1iBSQQOrkS3LUUi4-OUnVslQVChOCSuXPsxEXBkYmP733_MU5774sj1PxKXMC54XW6E4KaCSHzxzAcnQ-JvXnQHFFPTkWr6UAA9rMAhuE7Q3_ddYh4BIUzokscWyBjGh9yWRbMglbn3SlST-hoJaWsIVUoLRALciCGQUG6oUiB0rUbggIAytLqRhVBuVk4bH_ObK9lU_skdiiOGLAp-J4rsT2V4mcLrqz1_3bsV7-zll3NfhsV9f18LGrx8P-pb7Xz50Nt8bcG7MwD4-4uPtf6xuwP11p</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPUESTOS DERIVADOS DE IMIDAZOL CONDENSADOS, INHIBIDORES DEL FACTOR XA Y/O DEL FACTOR VLLA; COMPOSICION FARMACEUTICA; PROCESO DE PREPARACION; Y SU USO PARA TRATAR FIBRINOLISIS, LA FORMACION ANORMAL DE TROMBOS, INFARTO DE MIOCARDIO AGUDO, TRASTORNOS</title><source>esp@cenet</source><creator>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</creator><creatorcontrib>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</creatorcontrib><description>Benzimidazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I, wherein R ; R ; R ; R ; R ; Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.</description><edition>7</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050408&amp;DB=EPODOC&amp;CC=CL&amp;NR=2004001078A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050408&amp;DB=EPODOC&amp;CC=CL&amp;NR=2004001078A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</creatorcontrib><title>COMPUESTOS DERIVADOS DE IMIDAZOL CONDENSADOS, INHIBIDORES DEL FACTOR XA Y/O DEL FACTOR VLLA; COMPOSICION FARMACEUTICA; PROCESO DE PREPARACION; Y SU USO PARA TRATAR FIBRINOLISIS, LA FORMACION ANORMAL DE TROMBOS, INFARTO DE MIOCARDIO AGUDO, TRASTORNOS</title><description>Benzimidazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I, wherein R ; R ; R ; R ; R ; Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjzFPAzEMhW9hQIX_YIm1iBSQQOrkS3LUUi4-OUnVslQVChOCSuXPsxEXBkYmP733_MU5774sj1PxKXMC54XW6E4KaCSHzxzAcnQ-JvXnQHFFPTkWr6UAA9rMAhuE7Q3_ddYh4BIUzokscWyBjGh9yWRbMglbn3SlST-hoJaWsIVUoLRALciCGQUG6oUiB0rUbggIAytLqRhVBuVk4bH_ObK9lU_skdiiOGLAp-J4rsT2V4mcLrqz1_3bsV7-zll3NfhsV9f18LGrx8P-pb7Xz50Nt8bcG7MwD4-4uPtf6xuwP11p</recordid><startdate>20050408</startdate><enddate>20050408</enddate><creator>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</creator><scope>EVB</scope></search><sort><creationdate>20050408</creationdate><title>COMPUESTOS DERIVADOS DE IMIDAZOL CONDENSADOS, INHIBIDORES DEL FACTOR XA Y/O DEL FACTOR VLLA; COMPOSICION FARMACEUTICA; PROCESO DE PREPARACION; Y SU USO PARA TRATAR FIBRINOLISIS, LA FORMACION ANORMAL DE TROMBOS, INFARTO DE MIOCARDIO AGUDO, TRASTORNOS</title><author>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2004001078A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NAZARE MARC; WAGNER MICHAEL; WEHNER VOLKMAR; MATTER HANS; URMANN MATTHIAS; RITTER KURT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPUESTOS DERIVADOS DE IMIDAZOL CONDENSADOS, INHIBIDORES DEL FACTOR XA Y/O DEL FACTOR VLLA; COMPOSICION FARMACEUTICA; PROCESO DE PREPARACION; Y SU USO PARA TRATAR FIBRINOLISIS, LA FORMACION ANORMAL DE TROMBOS, INFARTO DE MIOCARDIO AGUDO, TRASTORNOS</title><date>2005-04-08</date><risdate>2005</risdate><abstract>Benzimidazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I, wherein R ; R ; R ; R ; R ; Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_CL2004001078A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMPUESTOS DERIVADOS DE IMIDAZOL CONDENSADOS, INHIBIDORES DEL FACTOR XA Y/O DEL FACTOR VLLA; COMPOSICION FARMACEUTICA; PROCESO DE PREPARACION; Y SU USO PARA TRATAR FIBRINOLISIS, LA FORMACION ANORMAL DE TROMBOS, INFARTO DE MIOCARDIO AGUDO, TRASTORNOS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A33%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NAZARE%20MARC;%20WAGNER%20MICHAEL;%20WEHNER%20VOLKMAR;%20MATTER%20HANS;%20URMANN%20MATTHIAS;%20RITTER%20KURT&rft.date=2005-04-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2004001078A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true